-
Natrecor: A Definitive Safety Study Is Long Overdue
Off-label Use Of Natrecor Continues To Be A Problem A year ago two medical journal articles raised serious safety issues about Natrecor; in summary: (1) a 50% increased risk of kidney damage or renal…
-
Merck’s New Vioxx Web Site: What Is This About?
The Drug Company Wants You To Know What It Thinks About The Vioxx Litigation Merck & Co. has turned to the Internet in order to further disseminate their positions concerning the ongoing Vioxx litigation…
-
Antibiotic Ketek: FDA Staff Recommends “Black-box” Warning
As Of May 1, 2006 There Are 23 Reports Of Serious Liver Injury, Including 12 Cases Of Liver Failure, In U.S. After finding the antibiotic Ketek (telithromycin) has been associated with 12 cases of…
-
Birth Control Patch Lawsuits Being Settled Early By Johnson & Johnson
Ortho Evra Contraceptive Patch Causes Blood Clots Resulting In Strokes, Heart Attacks, Pulmonary Embolism, And Deep Vein Thrombosis According to a May 16, 2006 article in the New Jersey Law Journal, Johnson & Johnson…
-
Already Poor Visibility In The Vioxx Litigation Seemingly Gets Worse
What Do The Latest Vioxx Study Results Mean, And What Will Merck Do? The assertions, claims, and interpretations about what the new data from the so-called "Approve" study means regarding any increased risk of…
-
What Is The Better Way To Improve Safety Of New Prescription Drugs?
Five Points For Consideration In May 2006 Circulation Editorial By Jerry Avorn, M.D. In May 2006 the medical journal Circulation published "Evaluating Drug Effects in the Post-Vioxx World — There Must Be a Better…
